CurrentEndo
Get Weekly

Topic · page 6 of 119

Type 2 & other diabetes

Type 2 diabetes and prediabetes: prevention, remission, glucose-lowering drugs, weight-based treatment, insulin, lifestyle and diet; monogenic and other specific types of diabetes

Briefs 201–240 of 4,758 placed here, newest publication first

Briefs in Type 2 & other diabetes

Newest publication first

  1. Diabet Med

    Social support and diabetes self‐care among African American adults with type 2 diabetes: A systematic review

    Meta-analysis

  2. Diabetologia

    Metabolic implications of hepatic, pancreatic and abdominal adipose tissue depots in Asian Indians across normoglycaemia, prediabetes and type 2 diabetes

    Cross-sectional study

  3. Diabetes Res Clin Pract

    The C-reactive protein-triglyceride-glucose index and its obesity-derived indicators predict cardio-renal-metabolic multimorbidity: evidence from the UK biobank and CHARLS

    Cohort study

  4. JAMA Intern Med

    Structured Telehealth Community Health Worker–Clinician Feedback and Diabetes Outcomes: A Randomized Clinical Trial

    Randomized controlled trial

  5. Diabetes Obes Metab

    Projecting the Long‐Term Cost‐Effectiveness of Once‐Weekly Insulin Icodec Versus Once‐Daily Basal Insulin Analogs in Italy Using the Prime T2D Model

    Research article

  6. Diabetes Res Clin Pract

    Cardiorenal-metabolic phenotypes and risks of mortality and cardiovascular outcomes in type 2 diabetes: a retrospective cohort study

    Cohort study

  7. Lancet

    Efficacy and safety of once-weekly subcutaneous zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in type 2 diabetes: a multicentre, randomised, parallel, double-blind, placebo-controlled, dose-finding, phase 2 trial

    Randomized controlled trial

  8. Lancet

    Efficacy and safety of once-daily oral zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in adults with type 2 diabetes: a multicentre, randomised, parallel, double-blind, placebo-controlled, dose-finding, phase 2 trial

    Randomized controlled trial

  9. Diabetes Obes Metab

    Feasibility of Decentralised Response‐Guided Albuminuria Monitoring to Optimise Empagliflozin and Finerenone Therapy in Type 2 Diabetes and Chronic Kidney Disease

    Research article

  10. Diabetes Obes Metab

    A New Highly Concentrated Insulin Aspart AT278 (500 U/ mL ) Demonstrates Ultra‐Rapid Pharmacokinetic and Pharmacodynamic Properties in Type 2 Diabetes Regardless of BMI

    Randomized controlled trial

  11. Diabetes Obes Metab

    Effect of Medications for Type 2 Diabetes on Cardiovascular Events and Mortality: A Comprehensive Pairwise and Network Meta‐Analysis

    Meta-analysis

  12. Diabetes Obes Metab

    Refining the Genetic Contribution to Type 2 Diabetes Subtypes

    Diagnostic or prognostic study

  13. Diabetes Res Clin Pract

    Cardiometabolic profile and cardiorenal complications across BMI categories in type 2 diabetes: A nationwide real-world analysis of over 500,000 patients

    Cross-sectional study

  14. Diabet Med

    Participants' experiences of a co‐adapted group‐based intervention to reduce diabetes distress in people with type 2 diabetes attending municipal rehabilitation services

    Research article

  15. Diabetes Res Clin Pract

    Ultra-processed foods and continuous glucose monitoring metrics in adults with type 2 diabetes

    Cross-sectional study

  16. Diabetes Care

    Emergency Hospitalization, Amputation, and Survival After Charcot Neuro-Osteoarthropathy Diagnosis in People With Diabetes: A Regional Registry-Based Cohort Study

    Cohort study

  17. Diabetes Res Clin Pract

    Efficacy of co-created, culturally-sensitive intervention for type 2 diabetes self-management education in immigrants in Italy: The DiabEthic randomized clinical trial

    Randomized controlled trial

  18. Diabetes Obes Metab

    Risk of Severe Hypoglycemia Associated With Concomitant Use of Sulfonylureas and Amiodarone

    Cohort study

  19. Cardiovasc Diabetol

    Effect of empagliflozin on copeptin levels in patients with recent acute coronary syndrome and newly detected dysglycaemia: a post-hoc analysis of the SOCOGAMI randomized controlled trial

    Secondary analysis

  20. Diabetes Obes Metab

    Economic Impact of Multidisciplinary Pre‐operative Diabetes Care Versus Usual Care in Adults Undergoing Elective Non‐cardiac Surgery in Australia: A Trial‐Based Analysis

    Cohort study

  21. Diabetes Obes Metab

    GLP ‐1 Receptor Agonists and Risk of Skin Cancer in Adults With Type 2 Diabetes: A Target Trial Emulation

    Research article

  22. Diabetes Obes Metab

    Sustained Use of SGLT2 Inhibitors and Cardiovascular Outcomes in Older Adults: A Landmark Cohort Study

    Cohort study

  23. Diabetes Res Clin Pract

    Circulating GDF15 levels reflect metabolic and inflammatory burden in early dysglycemia: findings from the ADIOS cohort

    Cross-sectional study

  24. Diabetologia

    Effects of time-restricted eating on markers of glucose metabolism and regulation in individuals with prediabetes or type 2 diabetes: a systematic review and meta-analysis of randomised controlled trials

    Meta-analysis

  25. Cardiovasc Diabetol

    Diabetic retinopathy enhances coronary artery calcium-based cardiovascular risk stratification in patients with type 2 diabetes: insights from the ACCoDiab study

    Cohort study

  26. J Diabetes Sci Technol

    Real-World Walking Patterns From Wrist-Worn Wearables Predict Incident Type 2 Diabetes: A UK Biobank WatchWalk Study

    Cohort study

  27. Obesity (Silver Spring)

    Time‐Restricted Eating on Appetite and Inflammation in Adults With Obesity and Prediabetes: A Randomized Feeding Study

    Secondary analysis

  28. Cardiovasc Diabetol

    Association of the triglyceride-glucose index with subclinical left ventricular dysfunction in type 2 diabetes mellitus: mediation by myocardial energetic efficiency and resting perfusion

    Cross-sectional study

  29. Diabetes Obes Metab

    Efficacy and Safety of Once‐Weekly Semaglutide 2.0 mg as an Add‐On to Dose‐Reduced Insulin Glargine versus Dose‐Titrated Insulin Glargine in People With Type 2 Diabetes and Overweight ( SUSTAIN OPTIMIZE )

    Randomized controlled trial

  30. Diabetologia

    Association of long-term exposure to air pollution, built environment and air temperature with the incidence of prediabetes phenotypes, and prediabetes remission and progression to type 2 diabetes: a longitudinal study in the KORA cohort

    Cohort study

  31. Diabetes Obes Metab

    Exercise Snacks Are Feasible to Perform in the Real World and Improve Physical Capacity for Adults Living With Non‐Insulin Treated Type 2 Diabetes: A Randomised Trial

    Randomized controlled trial

  32. Diabetes Res Clin Pract

    Cross-cultural adaptation, validation, and measurement invariance of the Italian version of the diabetes health literacy scale among Italian-born and foreign-born adults with type 2 diabetes mellitus

    Diagnostic or prognostic study

  33. Cardiovasc Diabetol

    Treatment with dapagliflozin and empagliflozin reduces concentrations of N4-acetylcytidine in plasma, a biomarker associated with vascular damage

    Mechanistic study

  34. Cardiovasc Diabetol

    Associations between cardiac adipose tissue volume, measures of coronary calcification, myocardial microvascular function and systemic inflammation in individuals with type 2 diabetes free of overt cardiovascular disease

    Cross-sectional study

  35. Diabetes Obes Metab

    Large‐Scale Plasma Proteomics Enhances Prediction of Liver‐Related Events Among Individuals With Prediabetes and Type 2 Diabetes: A Prospective Cohort Study in the UK Biobank

    Cohort study

  36. Cardiovasc Diabetol

    Genetically proxied glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide receptor pathway modulation is associated with favorable aging phenotypes: a drug-target Mendelian randomization study

    Research article

  37. Diabetes Obes Metab

    Joint Trajectories of Physical Activity and Depressive Symptoms and Incident Cardiometabolic Multimorbidity: A Multi‐Cohort Study

    Cohort study

  38. Diabetes Res Clin Pract

    Impact of modifiable risk factors, including diabetes, and diabetes-related complications, on dementia risk in older U.S. adults: mutually adjusted estimates from a population-based cohort

    Cohort study

  39. Diabet Med

    Diabetes overtreatment and flags for deprescribing glucose‐lowering treatment in geriatric inpatients with type 2 diabetes: Prognostic insights from a longitudinal cohort

    Cohort study

  40. BMJ

    Risk of hair loss associated with glucagon-like peptide-1 receptor agonists in adults with type 2 diabetes: target trial emulation

    Research article

All 4,758 Briefs in ExploreShowing Briefs 201–240 of 4,758, newest first